AlphaMaven

Company Logo'

Venture Capital

BioHealth Capital Fund

Healing the World One Investment at a Time
Back

Venture Capital

Andrea Alms Video: Money In Motion 10 - November 22, 2021

November 2021 - Venture Capital

posted by BioHealth Capital Fund
1w ago 3

Andrea Alms Money in Motion 10 - November 22, 2021


My name is Andrea ALMS.

I am biohealth investor, and financial manager and this is your Money in Motion

I was asked about the Tryptophan investing…

What is tryptophan…

·        This Thanksgiving, you are going to get tired -- that's pretty much guaranteed.

·        But while you may blame the turkey, and its purportedly high tryptophan levels, maybe it's just the conversation with your aunt about her recent sheriff controversies

·        Or is it the handfuls of Parmesan cheese you're sneaking in the kitchen between courses

·        Turns out many foods also contain the drowsiness-inducing amino acid tryptophan, often in levels far surpassing the famous gobbler.

·        Like Parmesan cheese! And pork! And soybeans!

·        And, spirulina, a dietary supplement containing photosynthetic bacteria!

·        So, maybe next time make an algae casserole if you really want a good food-sleep.

What is the L-Tryptophan Market?

·        According to the research analysis, global L-Tryptophan market is set to record a 22.8% CAGR during 2019-2025.

·        This business domain is likely to account for 1.7 billion in 2025 from about $780 Million dollars it previously generated in 2019.

·        By application, tryptophan is in demand in feed and pharmaceutical industry

·        Key players include CJ, Ajinomoto and so on

What about investing in this market and the global amino acid market

·        The Global Amino Acid Market size was estimated 28 Billion in 2020 and expected to reach USD 30  Billion in 2021, at a Compound Annual Growth Rate 6% to reach USD 40 by 2026.

·        The L-trytophan is at 22.8% and a strong performer in that market

·        Good stats and

·        Food for thought…Happy Thanksgiving

Thank you

·       This is your money – your money in motion

 

 

Credits and References – Thank You

·       BioHealth Innovation

·       BioHealth Capital Region Forum Archives

·       Geoff Marcus and AlpaMaven

·       https://carofin.com/knowledge-base/industry/angel-and-venture-alert-the-case-for-investing-in-orphan-drugs/

·       https://www.alliedmarketresearch.com/orphan-drug-market

·        

·       https://www.fda.gov/industry/orphan-products-development-events/story-behind-orphan-drug-act

·       https://www.dcatvci.org/features/orphan-drugs-bearing-revenue-gains-or-not/#:~:text=Between%202015%20and%202019%2C%20orphan,which%20represented%20a%20recent%20high.

·       https://pharmaboardroom.com/articles/investments-and-deal-activity-in-orphan-drug-products/

·        

·        


ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.